RETEVASE Side Effects

5202480-0 | Hypotension
on Dec 19, 2005 Female patient from UNITED STATES , 65 years of age, weighting 189.6 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension. Retevase dosage: Iv. During the same period patient was treated with REOPRO (Iv) (View Reopro Review and Reopro Label ), ATROPINE (View Atropine Review and Atropine Label ), DOPAMINE HCL (View Dopamine Hcl Review and Dopamine Hcl Label ), ROFECOXIB (View Rofecoxib Review and Rofecoxib Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), MORPHINE (View Morphine Review and Morphine Label ).

5202444-7 | Cardiogenic Shock, Ventricular Arrhythmia
Patient was taking Retevase (View Usage). Patient had the following side effects: cardiogenic shock, ventricular arrhythmia on Aug 24, 2005 from UNITED STATES Additional patient health information: Male patient , 79 years of age, was diagnosed with acute myocardial infarction and. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), CARBASALATE CALCIUM (View Carbasalate Calcium Review and Carbasalate Calcium Label ).

5202443-5 | Ventricular Fibrillation
Adverse event was reported on Aug 19, 2005 by a Male patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 72 years of age, After Retevase was administered, patient had the following side effects: ventricular fibrillation. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ).

5110865-6 | Angina Pectoris, Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb Increased, Blood Creatinine Decreased, Blood Pressure Diastolic Increased, Blood Pressure Systolic Increased, Cardiac Imaging Procedure Abnormal, Coronary Artery Thrombosis, Ejection Fraction Decreased
on Sep 18, 2006 Male patient from ITALY , 58 years of age, weighting 202.8 lb, was diagnosed with myocardial infarction, acute myocardial infarction and was treated with Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, blood creatine phosphokinase increased, blood creatine phosphokinase mb increased, blood creatinine decreased, blood pressure diastolic increased, blood pressure systolic increased, cardiac imaging procedure abnormal, coronary artery thrombosis, ejection fraction decreased. Retevase dosage: 5 Iu;x1; Iv. During the same period patient was treated with REOPRO (See Image, Iv) (View Reopro Review and Reopro Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.


5104185-3 | Haematemesis, Haematocrit Decreased, Haemoglobin Decreased, Rectal Haemorrhage
on Sep 07, 2006 Male patient from UNITED KINGDOM , 85 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient had the following side effects: haematemesis, haematocrit decreased, haemoglobin decreased, rectal haemorrhage. Retevase dosage: Iv. During the same period patient was treated with REOPRO (Iv) (View Reopro Review and Reopro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

5102338-1 | Cardiac Arrest, Chest Pain, Dilatation Ventricular, Dyspnoea Exertional, Haemodynamic Instability, Hypoxia, Pulmonary Arterial Pressure Increased, Pulmonary Embolism, Subclavian Vein Thrombosis
Patient was taking Retevase (View Usage). After Retevase was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), chest pain (What is chest pain?), dilatation ventricular, dyspnoea exertional, haemodynamic instability, hypoxia, pulmonary arterial pressure increased, pulmonary embolism (What is pulmonary embolism?), subclavian vein thrombosis on Aug 29, 2006 from UNITED STATES Additional patient health information: Male patient , 17 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?) and. Retevase dosage: .

5086873-0 | Myocardial Infarction
Adverse event was reported on Aug 11, 2006 by a Male patient taking Retevase (View Usage) (Dosage: 0.5 U; Qh; Iart) was diagnosed with arterial occlusive disease and. Location: UNITED STATES , 84 years of age, Patient experienced the following unwanted or unexpected effects: myocardial infarction.

5015307-7 | Arterial Thrombosis, Cerebral Haemorrhage, Haematocrit Decreased, Headache, Infusion Related Reaction, International Normalised Ratio Decreased, Mydriasis, Pupil Fixed
on May 30, 2006 Female patient from UNITED STATES , 52 years of age, weighting 140.0 lb, was diagnosed with thrombolysis and was treated with Retevase (View Usage). Patient had the following side effects: arterial thrombosis, cerebral haemorrhage, haematocrit decreased, headache (What is headache?), infusion related reaction, international normalised ratio decreased, mydriasis, pupil fixed. Retevase dosage: 0.5 Units/hr. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

4971715-1 | Aggression, Agitation, Blood Albumin Decreased, Blood Calcium Decreased, Blood Creatine Phosphokinase Mb Increased, Blood Glucose Increased, Bundle Branch Block Left, Cardiac Arrest, Cardiac Failure Congestive
on Mar 24, 2006 Male patient from UNITED STATES , 74 years of age, weighting 155.2 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). After Retevase was administered, patient had the following side effects: aggression, agitation, blood albumin decreased, blood calcium decreased, blood creatine phosphokinase mb increased, blood glucose increased, bundle branch block left, cardiac arrest (What is cardiac arrest?), cardiac failure congestive. Retevase dosage: Iv. During the same period patient was treated with REOPRO (Iv) (View Reopro Review and Reopro Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), LASIX (View Lasix Review and Lasix Label ), COREG (View Coreg Review and Coreg Label ), VASOTEC (View Vasotec Review and Vasotec Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

4964393-9 | Acute Myocardial Infarction, Cardiac Tamponade, Cardiogenic Shock, Coronary Artery Disease, Ventricle Rupture, Ventricular Septal Defect
Patient was taking Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, cardiac tamponade, cardiogenic shock, coronary artery disease (What is coronary artery disease?), ventricle rupture, ventricular septal defect on Mar 17, 2006 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 240.3 lb, was diagnosed with acute myocardial infarction and. Retevase dosage: 5 Iu; 1x; Iv. Patient was hospitalized.

4953871-4 | Acute Prerenal Failure, Aggression, Agitation, Blood Albumin Decreased, Blood Calcium Decreased, Blood Glucose Increased, Bundle Branch Block Left, Cardiac Failure Congestive, Cardio-respiratory Arrest
Adverse event was reported on Mar 07, 2006 by a Male patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 74 years of age, weighting 155.2 lb, Patient had the following side effects: acute prerenal failure, aggression, agitation, blood albumin decreased, blood calcium decreased, blood glucose increased, bundle branch block left, cardiac failure congestive, cardio-respiratory arrest. During the same period patient was treated with ABCIXIMAB (Iv) (View Abciximab Review and Abciximab Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), LASIX (View Lasix Review and Lasix Label ), COREG (View Coreg Review and Coreg Label ), VASOTEC (View Vasotec Review and Vasotec Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

4928265-8 | Haematology Test Abnormal, Haemolysis
on Feb 09, 2006 Male patient from UNITED STATES , 58 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and was treated with Retevase (View Usage). After Retevase was administered, patient had the following side effects: haematology test abnormal, haemolysis. Retevase dosage: Iv. Patient was hospitalized.

4919272-X | Cardiac Procedure Complication, Cardiogenic Shock, Coronary Artery Disease, Ventricular Septal Defect
on Feb 03, 2006 Male patient from UNITED STATES , 70 years of age, weighting 240.3 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac procedure complication, cardiogenic shock, coronary artery disease (What is coronary artery disease?), ventricular septal defect. Retevase dosage: 5 Iu; 1x; Iv. Patient was hospitalized.

4898746-4 | Cardiogenic Shock, Coronary Artery Disease, Procedural Complication, Ventricular Septal Defect
Patient was taking Retevase (View Usage). Patient had the following side effects: cardiogenic shock, coronary artery disease (What is coronary artery disease?), procedural complication, ventricular septal defect on Jan 12, 2006 from UNITED STATES Additional patient health information: Male patient , 70 years of age, weighting 240.3 lb, was diagnosed with acute myocardial infarction and. Retevase dosage: 5 Iu; 1x; Iv. Patient was hospitalized.

4898345-4 | Benign Prostatic Hyperplasia, Urinary Retention
Adverse event was reported on Jan 12, 2005 by a Male patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 85 years of age, weighting 180.8 lb, After Retevase was administered, patient had the following side effects: benign prostatic hyperplasia, urinary retention. During the same period patient was treated with ABCIXIMAB (Iv) (View Abciximab Review and Abciximab Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ). Patient was hospitalized.

4878489-3 | Coronary Artery Disease, Ventricular Septal Defect
on Jan 10, 2006 Male patient from UNITED STATES , weighting 240.3 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery disease (What is coronary artery disease?), ventricular septal defect. Retevase dosage: 5+5 Units Iv Push. Patient was hospitalized.

4862997-5 | Urinary Retention
on Dec 05, 2005 Male patient from UNITED STATES , 87 years of age, weighting 180.8 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient had the following side effects: urinary retention. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (Iv) (View Abciximab Review and Abciximab Label ). Patient was hospitalized.

4847153-9 | Chest Pain, Ecchymosis, Haemorrhage Intracranial, Parkinson's Disease
Patient was taking Retevase (View Usage). After Retevase was administered, patient had the following side effects: chest pain (What is chest pain?), ecchymosis, haemorrhage intracranial, parkinson's disease (What is parkinson's disease?) on Nov 21, 2005 from UNITED STATES Additional patient health information: Male patient , 75 years of age, weighting 198.0 lb, was diagnosed with chest pain (What is chest pain?) and. Retevase dosage: X1;iv. Patient was hospitalized.

4846256-2 | Chest Pain
Adverse event was reported on Nov 16, 2005 by a Female patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 55 years of age, Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?). During the same period patient was treated with ABCIXIMAB (Iv) (View Abciximab Review and Abciximab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), THYROID TAB (View Thyroid Tab Review and Thyroid Tab Label ). Patient was hospitalized.

4820240-7 | Haemorrhage
on Mar 08, 2005 Male patient from UNITED STATES , 77 years of age, was treated with Retevase (View Usage). Patient had the following side effects: haemorrhage. Retevase dosage: Intravenous. Patient was hospitalized.

4820235-3 | Haemorrhage Intracranial
on Apr 11, 2005 Male patient from UNITED STATES , 66 years of age, weighting 224.9 lb, was diagnosed with ischaemic stroke and was treated with Retevase (View Usage). After Retevase was administered, patient had the following side effects: haemorrhage intracranial. Retevase dosage: 10 Iu, 2 In 1 Total, Intravenous. During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), STARLIX (View Starlix Review and Starlix Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ISOSORBIDE (ISOSORBIDE) (View Isosorbide (isosorbide) Review and Isosorbide (isosorbide) Label ). Patient was hospitalized.

4820234-1 | Myocardial Infarction
Patient was taking Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction on Mar 23, 2005 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with myocardial infarction and. Retevase dosage: 10 Iu, 1 In 1 Total, Intravenous.

4802188-7 | Myocardial Ischaemia
Adverse event was reported on Sep 30, 2005 by a Male patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 55 years of age, weighting 202.8 lb, Patient had the following side effects: myocardial ischaemia. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

4801926-7 | Dilatation Ventricular, Dyspnoea, Ejection Fraction Decreased, Electrocardiogram T Wave Inversion, Ventricular Dysfunction
on Sep 30, 2005 Male patient from UNITED STATES , 61 years of age, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). After Retevase was administered, patient had the following side effects: dilatation ventricular, dyspnoea, ejection fraction decreased, electrocardiogram t wave inversion, ventricular dysfunction. Retevase dosage: . During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), WARFARIN (View Warfarin Review and Warfarin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ). Patient was hospitalized.

4801925-5 | Coronary Artery Stenosis, Ejection Fraction Decreased, Ventricular Hypokinesia
on Sep 30, 2005 Male patient from UNITED STATES , 47 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery stenosis, ejection fraction decreased, ventricular hypokinesia. Retevase dosage: . During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ORGANIC NITRATES (View Organic Nitrates Review and Organic Nitrates Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

4801921-8 | Atrial Fibrillation, Cardiac Failure
Patient was taking Retevase (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure on Sep 26, 2005 from UNITED STATES Additional patient health information: Female patient , 83 years of age, weighting 114.6 lb, was diagnosed with acute myocardial infarction and. Retevase dosage: . During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ORGANIC NITRATES (View Organic Nitrates Review and Organic Nitrates Label ).

4800926-0 | Blood Pressure Decreased, Cardiac Arrest, Fall, Lower Respiratory Tract Infection, Myocardial Infarction, Renal Impairment, Staphylococcal Infection, Ventricular Fibrillation
Adverse event was reported on Sep 23, 2005 by a Male patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED KINGDOM , 51 years of age, After Retevase was administered, patient had the following side effects: blood pressure decreased, cardiac arrest (What is cardiac arrest?), fall (What is fall?), lower respiratory tract infection, myocardial infarction, renal impairment, staphylococcal infection (What is staphylococcal infection?), ventricular fibrillation. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), NICORANDIL (View Nicorandil Review and Nicorandil Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), ROSUVASTATIN (View Rosuvastatin Review and Rosuvastatin Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ). Patient was hospitalized.

4800925-9 | Blood Glucose Decreased, Cerebral Infarction, Dizziness, Hypotension, Leukocyturia, Malaise, Nausea, Pyrexia, Tachycardia
on Sep 23, 2005 Female patient from DENMARK , 84 years of age, weighting 165.3 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, cerebral infarction, dizziness (What is dizziness?), hypotension, leukocyturia, malaise, nausea (What is nausea?), pyrexia, tachycardia. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), SULFAMETHIZOLE TAB (View Sulfamethizole Tab Review and Sulfamethizole Tab Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), ALBYL ENTEROSOLUBILE (View Albyl-enterosolubile Review and Albyl-enterosolubile Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

4800924-7 | Aortic Valve Incompetence, Atrial Fibrillation, Cardiac Arrest, Cardiovascular Disorder, Dilatation Atrial, Dilatation Ventricular, Disease Recurrence, Mitral Valve Incompetence, Mitral Valve Prolapse
on Sep 23, 2005 Male patient from ITALY , 64 years of age, weighting 141.1 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient had the following side effects: aortic valve incompetence, atrial fibrillation (What is atrial fibrillation?), cardiac arrest (What is cardiac arrest?), cardiovascular disorder, dilatation atrial, dilatation ventricular, disease recurrence, mitral valve incompetence, mitral valve prolapse. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), WARFARIN (View Warfarin Review and Warfarin Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), CHOLESTEROL AND TRIGLYCERIDE REDUCERS (View Cholesterol- And Triglyceride Reducers Review and Cholesterol- And Triglyceride Reducers Label ), LASIX (View Lasix Review and Lasix Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

4800923-5 | Cardiac Arrest, Coronary Artery Disease, Ejection Fraction Decreased, Ventricular Fibrillation
Patient was taking Retevase (View Usage). After Retevase was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), coronary artery disease (What is coronary artery disease?), ejection fraction decreased, ventricular fibrillation on Sep 26, 2005 from UNITED KINGDOM Additional patient health information: Male patient , 76 years of age, was diagnosed with acute myocardial infarction and. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), DILATREND (View Dilatrend Review and Dilatrend Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), KETONAL (View Ketonal Review and Ketonal Label ). Patient was hospitalized.

4800922-3 | Pneumonia, Respiratory Failure, Ventricular Fibrillation
Adverse event was reported on Sep 26, 2005 by a Male patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 70 years of age, weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), respiratory failure, ventricular fibrillation. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

4800921-1 | Acute Psychosis, Gastrointestinal Haemorrhage, Haematemesis
on Sep 26, 2005 Female patient from UNITED STATES , 73 years of age, weighting 143.3 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient had the following side effects: acute psychosis, gastrointestinal haemorrhage, haematemesis. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

4800870-9 | Coronary Artery Stenosis
on Sep 26, 2005 Male patient from UNITED STATES , 52 years of age, weighting 222.7 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). After Retevase was administered, patient had the following side effects: coronary artery stenosis. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

4800868-0 | Bronchitis, Lung Neoplasm
Patient was taking Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), lung neoplasm on Sep 26, 2005 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with acute myocardial infarction and. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ). Patient was hospitalized.

4799985-3 | Angina Pectoris
Adverse event was reported on Sep 30, 2005 by a Male patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 83 years of age, weighting 165.3 lb, Patient had the following side effects: angina pectoris. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4799984-1 | Acquired Diaphragmatic Eventration, Adhesion, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Emphysema, Haematocrit Decreased, Hiatus Hernia
on Sep 30, 2005 Female patient from UNITED STATES , 72 years of age, weighting 127.9 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). After Retevase was administered, patient had the following side effects: acquired diaphragmatic eventration, adhesion (What is adhesion?), chronic obstructive pulmonary disease, condition aggravated, emphysema, haematocrit decreased, hiatus hernia. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), FURON (View Furon Review and Furon Label ). Patient was hospitalized.

4787251-1 | Bronchitis
on Sep 16, 2005 Female patient from UNITED KINGDOM , 57 years of age, weighting 187.4 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?). Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), OMACOR (View Omacor Review and Omacor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

4787095-0 | Haemodialysis, Post Procedural Complication, Renal Failure Acute
Patient was taking Retevase (View Usage). Patient had the following side effects: haemodialysis, post procedural complication, renal failure acute on Sep 16, 2005 from ITALY Additional patient health information: Female patient , 41 years of age, was diagnosed with acute myocardial infarction and. Retevase dosage: . During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ).

4787091-3 | Chest Pain, Dyspnoea, Troponin I Increased
Adverse event was reported on Sep 15, 2005 by a Male patient taking Retevase (View Usage) (Dosage: ) was diagnosed with acute myocardial infarction and. Location: UNITED KINGDOM , 70 years of age, weighting 183.0 lb, After Retevase was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea, troponin i increased. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), GLYCERYL TRINITRATE (View Glyceryl Trinitrate Review and Glyceryl Trinitrate Label ). Patient was hospitalized.

4785461-0 | Angina Pectoris, Dyspnoea, Electrocardiogram Poor R-wave Progression, Electrocardiogram St Segment Depression, Electrocardiogram T Wave Abnormal, Gastrointestinal Haemorrhage, Haemoglobin Decreased, Rectal Cancer
on Sep 15, 2005 Male patient from UNITED KINGDOM , 56 years of age, weighting 154.3 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, dyspnoea, electrocardiogram poor r-wave progression, electrocardiogram st segment depression, electrocardiogram t wave abnormal, gastrointestinal haemorrhage, haemoglobin decreased, rectal cancer. Retevase dosage: 5 Iu; X2; Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (3.3 Ml; Qh; Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

4784191-9 | Fall, Hyponatraemia, Loss Of Consciousness
on Sep 13, 2005 Male patient from UNITED STATES , 85 years of age, weighting 172.0 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient had the following side effects: fall (What is fall?), hyponatraemia, loss of consciousness. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (Iv) (View Abciximab Review and Abciximab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), TAMSULOSIN (View Tamsulosin Review and Tamsulosin Label ), CANDESARTAN (View Candesartan Review and Candesartan Label ). Patient was hospitalized.

4783690-3 | Chronic Obstructive Pulmonary Disease, Emphysema
Patient was taking Retevase (View Usage). After Retevase was administered, patient had the following side effects: chronic obstructive pulmonary disease, emphysema on Sep 13, 2005 from CZECH REPUBLIC Additional patient health information: Female patient , 72 years of age, weighting 127.9 lb, was diagnosed with acute myocardial infarction and. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ). Patient was hospitalized.

4783688-5 | Coronary Artery Disease
Adverse event was reported on Sep 13, 2005 by a Female patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED KINGDOM , 54 years of age, Patient experienced the following unwanted or unexpected effects: coronary artery disease (What is coronary artery disease?). During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ).

4783684-8 | Coronary Artery Disease
on Sep 12, 2200 Female patient from CZECH REPUBLIC , 71 years of age, weighting 172.0 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient had the following side effects: coronary artery disease (What is coronary artery disease?). Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METFORMIN (View Metformin Review and Metformin Label ), GLIBENCLAMIDE (View Glibenclamide Review and Glibenclamide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ). Patient was hospitalized.

4782747-0 | Coronary Artery Disease
on Sep 12, 2005 Male patient from UNITED STATES , 76 years of age, weighting 172.0 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). After Retevase was administered, patient had the following side effects: coronary artery disease (What is coronary artery disease?). Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALL THERAPEUTIC PRODUCTS (View All Therapeutic Products Review and All Therapeutic Products Label ), PIRACETAM (View Piracetam Review and Piracetam Label ), AMINOPHYLLINE (View Aminophylline Review and Aminophylline Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

4782709-3 | Chest Pain, Gastric Ulcer
Patient was taking Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), gastric ulcer on Sep 12, 2200 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 216.1 lb, was diagnosed with acute myocardial infarction and. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), DIURETICS (View Diuretics Review and Diuretics Label ). Patient was hospitalized.

4782665-8 | Coronary Artery Stenosis
Adverse event was reported on Sep 12, 2005 by a Male patient taking Retevase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 47 years of age, weighting 176.4 lb, Patient had the following side effects: coronary artery stenosis. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ORGANIC NITRATES (View Organic Nitrates Review and Organic Nitrates Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ).

4781599-2 | Coronary Artery Stenosis, Dementia, Full Blood Count Decreased, Haematocrit Decreased, Haemoglobin Decreased
on Sep 26, 2005 Female patient from UNITED KINGDOM , 75 years of age, weighting 123.5 lb, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). After Retevase was administered, patient had the following side effects: coronary artery stenosis, dementia (What is dementia?), full blood count decreased, haematocrit decreased, haemoglobin decreased. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ASCORUTIN (View Ascorutin Review and Ascorutin Label ). Patient was hospitalized.

4781595-5 | Coronary Artery Stenosis
on Sep 12, 2005 Female patient from UNITED KINGDOM , 67 years of age, was diagnosed with acute myocardial infarction and was treated with Retevase (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery stenosis. Retevase dosage: Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (Iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), FLUVASTATIN (View Fluvastatin Review and Fluvastatin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

4781028-9 | Coronary Artery Stenosis
Patient was taking Retevase (View Usage). Patient had the following side effects: coronary artery stenosis on Sep 22, 2005 from CZECH REPUBLIC Additional patient health information: Female patient , 72 years of age, weighting 147.7 lb, was diagnosed with acute myocardial infarction and. Retevase dosage: Iv. During the same period patient was treated with ABICIXIMAB (ABICIXIMAB) (Iv) (View Abiciximab (abiciximab) Review and Abiciximab (abiciximab) Label ). Patient was hospitalized.